Ads
related to: genetic resistance to hiv therapy benefits- Treatment Costs & Savings
See If You Are Eligible For Savings
Or Assistance Programs.
- Get Treatment Resources
See Tools Specifically For Patients
About Dosing, Savings And More.
- Long-Acting HIV Treatment
An Injection Just Every Other Month
With A Flexible Treatment Window.
- Helpful Resources
Learn About An HIV Treatment
And Discover More About Dosing.
- Important Safety Info
Learn About Possible Side Effects
And View Important Safety Info.
- Helpful Patient Tools
Find Information For Patients Here.
Visit The Official Patient Website.
- Treatment Costs & Savings
Search results
Results From The WOW.Com Content Network
Innate resistance to HIV. A small proportion of humans show partial or apparently complete innate resistance to HIV, the virus that causes AIDS. [1] The main mechanism is a mutation of the gene encoding CCR5, which acts as a co-receptor for HIV. It is estimated that the proportion of people with some form of resistance to HIV is under 10%.
HIV drug resistance occurs when microevolution causes virions to become tolerant to antiretroviral treatments (ART). ART can be used to successfully manage HIV infection, but a number of factors can contribute to the virus mutating and becoming resistant. Drug resistance occurs as bacterial or viral populations evolve to no longer respond to ...
The management of HIV/AIDS normally includes the use of multiple antiretroviral drugs as a strategy to control HIV infection. [1] There are several classes of antiretroviral agents that act on different stages of the HIV life-cycle. The use of multiple drugs that act on different viral targets is known as highly active antiretroviral therapy ...
HIV protease inhibitors are peptide-like chemicals that competitively inhibit the action of the virus aspartyl protease. These drugs prevent proteolytic cleavage of HIV Gag and Pol polyproteins that include essential structural and enzymatic components of the virus. This prevents the conversion of HIV particles into their mature infectious form.
As of April 2013, two primary approaches are being pursued in the search for a HIV cure: The first is gene therapy that aims to develop a HIV-resistant immune system for patients, and the second is being led by Danish scientists, who are conducting clinical trials to strip the HIV from human DNA and have it destroyed permanently by the immune ...
Resistance ranged from 3.9% to 8.6% and reached 19.6% among people who have received and transitioned to a dolutegravir-containing antiretroviral therapy (ART) regimen to combat high HIV viral loads.
Ads
related to: genetic resistance to hiv therapy benefits